Literature DB >> 20810574

Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome.

Ohn Nyunt1, Andrew M Cotterill, Sinead M Archbold, Joyce Y Wu, Gary M Leong, Charles F Verge, Patricia A Crock, Geoffrey R Ambler, Paul Hofman, Mark Harris.   

Abstract

INTRODUCTION: It has been postulated that central adrenal insufficiency (CAI), resulting from hypothalamic dysfunction, may contribute to the increased unexplained death rates in Prader Willi syndrome (PWS). A study using the overnight metyrapone test reported a 60% prevalence of CAI in children with PWS. We used a low-dose Synacthen test to screen for CAI in children with PWS.
METHODS: We studied 41 children with genetic diagnosis of PWS [20 males; mean age, 7.68 (±5.23) yr] in five pediatric endocrinology centers in Australasia. All participants were randomly selected, and none had a history of Addisonian crisis. Ten of the cohort were receiving sex hormone therapy, 19 were receiving GH, and four were receiving T4. Their mean body mass index z-score was +1.48 (±1.68). Baseline morning ACTH and cortisol levels were measured, followed by iv administration of 1 μg Synacthen. Post-Synacthen cortisol levels were measured at 30 min, and a cortisol level above 500 nmol/liter was considered normal.
RESULTS: The mean baseline ACTH and cortisol were 15 (±14) ng/liter and 223 (±116) nmol/liter, respectively. The mean 30-min plasma cortisol was 690 (±114) nmol/liter, and the average increase from baseline was 201%.
CONCLUSIONS: Our result suggests that CAI is rare in children with PWS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810574     DOI: 10.1210/jc.2010-0647

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

3.  Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice.

Authors:  Alysa A Tennese; Rachel Wevrick
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 4.  Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.

Authors:  Giovanna Muscogiuri; Gloria Formoso; Gabriella Pugliese; Rosaria Maddalena Ruggeri; Elisabetta Scarano; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

5.  Severe Hypoglycemia due to Isolated ACTH Deficiency in Children: A New Case Report and Review of the Literature.

Authors:  Michael Y Torchinsky; Robert Wineman; George W Moll
Journal:  Int J Pediatr       Date:  2011-03-30

6.  Prader-Willi syndrome: A primer for clinicians.

Authors:  Mary Cataletto; Moris Angulo; Gila Hertz; Barbara Whitman
Journal:  Int J Pediatr Endocrinol       Date:  2011-10-18

Review 7.  Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.

Authors:  M A Angulo; M G Butler; M E Cataletto
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

8.  Prader-willi syndrome: clinical aspects.

Authors:  Grechi Elena; Cammarata Bruna; Mariani Benedetta; Di Candia Stefania; Chiumello Giuseppe
Journal:  J Obes       Date:  2012-10-23

9.  Endocrine manifestations and management of Prader-Willi syndrome.

Authors:  Jill E Emerick; Karen S Vogt
Journal:  Int J Pediatr Endocrinol       Date:  2013-08-21

10.  Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome.

Authors:  Veronique Beauloye; K Dhondt; W Buysse; A Nyakasane; F Zech; J De Schepper; S Van Aken; K De Waele; M Craen; I Gies; I Francois; D Beckers; A Desloovere; G Francois; M Cools
Journal:  Orphanet J Rare Dis       Date:  2015-09-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.